Vera Therapeutics, Inc.
VERA
$37.25
$4.2512.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.12% | 37.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.73% | 40.12% | |||
| Operating Income | -4.73% | -40.12% | |||
| Income Before Tax | -4.92% | -48.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.92% | -48.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.92% | -48.05% | |||
| EBIT | -4.73% | -40.12% | |||
| EBITDA | -4.72% | -40.12% | |||
| EPS Basic | -4.83% | -47.76% | |||
| Normalized Basic EPS | -4.83% | -47.77% | |||
| EPS Diluted | -4.83% | -47.76% | |||
| Normalized Diluted EPS | -4.83% | -47.77% | |||
| Average Basic Shares Outstanding | 0.09% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||